Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Janux Therapeutics JANX Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.78M	Hold	376,496	–	–	0.32%	31
2026 Q1	$5.23M	Hold	376,496	–	–	0.44%	34
2025 Q4	$5.2M	Hold	376,496	–	–	0.46%	30
2025 Q3	$9.2M	Hold	376,496	–	–	0.71%	27
2025 Q2	$8.7M	Hold	376,496	–	–	1.03%	23
2025 Q1	$10.2M	Sell	376,496 -52,896	-12%	-$1.99M	2.1%	17
2024 Q4	$23M	Sell	429,392 -42,344	-9%	-$2.24M	2.78%	17
2024 Q3	$21.4M	Buy	+471,736	New	+$20.5M	2.97%	15

Other funds holding JANX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's JANX Position: Q2 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held its Janux Therapeutics (JANX) position steady in Q2 2026 at 376,496 shares worth $5.78M. The position accounts for 0.32% of the portfolio, ranked #31.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in JANX in Q3 2024 and has held it in 8 quarters since. The position peaked at $23M in Q4 2024. 103 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held 376,496 shares of Janux Therapeutics worth $5.78M as of Q2 2026.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne left its Janux Therapeutics share count unchanged in Q2 2026.
Janux Therapeutics made up 0.32% of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's portfolio in Q2 2026, its #31 holding.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Janux Therapeutics in Q3 2024 and has held it in 8 quarters since.
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Janux Therapeutics position peaked at $23M in Q4 2024.
103 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2026, filed 7 Aug 2026.